-
Innovation Ranking
NewInnovation Ranking – BGI Genomics Co Ltd
BGI Genomics Co Ltd (BGI Genomics), a subsidiary of Beijing BGI-GBI Biotech Co Ltd BGI, provides next generation sequencing services and genetic tests. The company offers services including DNA (deoxyribonucleic acid) sequencing, RNA (ribonucleic acid) sequencing, non-invasive prenatal testing, newborn genetic screening, reproductive health screening, customized sequencing services and clinical exome sequencing services. BGI Genomics also conducts research to advance precision medicine and diagnostics in the fields of metagenomics, reproductive health and for detecting cancer. It serves various medical institutions,...
-
Company Insights
Innovation and Patenting activity of BGI Genomics Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BGI Genomics Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Prenatal Screening Market Report Overview The prenatal screening market size was $672.8 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Pre-natal screening describes tests that detect potential problems affecting the viability and development of the fetus. The detection is carried out using both less invasive and more invasive sampling techniques. Prenatal Screening Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Prenatal Screening Market Forecast...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. Severe Acute Respiratory Syndrome Coronavirus, SARS‐CoV‐2, a novel coronavirus from the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has spread worldwide leading the World Health Organization (WHO) to declare a pandemic. The disease caused by SARS‐CoV‐2, coronavirus disease 2019 (COVID‐19), presents flu‐like symptoms that can become serious in high‐risk individuals, is a rapidly evolving situation across the globe, and has...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments · Other Colorectal Cancer Screening Tests · Fecal DNA Test Kits · Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories · The US · Europe...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BRAF Tests Market Report Overview The BRAF Tests market size was valued at $32.8 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. BRAF Sanger sequencing Tests are used when complete sequencing of the BRAF gene is required for accurate detection and mapping of mutations. Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs). BRAF Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for More...
-
Company Insights
Top Biotechnology Foreign Direct Investment Companies
Top Biotechnology Foreign Direct Investment Companies report analyzes the most active greenfield FDI investors globally (based on number of projects) in the Biotechnology sector between Q1 2019 and Q3 2023. Additionally, the report highlights where these top Biotechnology investors are investing in what type of operations. The report also provides an overview of notable FDI projects from these top investors. The report will be delivered within 2-3 business days of the purchase, excluding weekends and holidays. Certain sections of the...
-
Thematic Analysis
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Thematic Analysis
Impact of China on Medical Devices Industry – Thematic Intelligence
Impact of China on Medical Devices Industry Report Overview China is among the top 10 largest medical device markets worldwide and is regarded as one of the most promising. The estimated market value of medical devices in China was $44.8 billion in 2023, accounting for around 8% of the world total. China’s medical devices market is forecast to grow at a CAGR of more than 5% through 2025. The key market drivers include the country’s aging population, increasing chronic conditions,...